Invivyd (IVVD) Share-based Compensation (2020 - 2025)

Invivyd (IVVD) posted Share-based Compensation of $2.6 million for Q4 2025, down 79.81% on a QoQ basis from $12.7 million in Q3 2025, and down 16.13% year-over-year from $3.1 million in Q4 2024.

Invivyd (IVVD) Share-based Compensation (2020 - 2025) Analysis & Trends

Invivyd's Share-based Compensation history runs 6 years deep, the most recent figure standing at $2.6 million for Q4 2025.

  • Quarterly Share-based Compensation fell 16.13% year-over-year to $2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.7 million (down 41.05% YoY) and the FY2025 annual result came in at $11.6 million, down 41.16% from the prior year.
  • Share-based Compensation was $2.6 million for Q4 2025 at Invivyd, down from $12.7 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $19.9 million in Q4 2022 and bottomed at -$9.9 million in Q4 2021.
  • A 5-year average of $5.6 million and a median of $4.5 million in 2023 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2021 — Share-based Compensation slumped 10008.0% — and 2025, when it surged 343.13%.
  • Invivyd's Share-based Compensation stood at -$9.9 million in 2021, then jumped by 301.05% to $19.9 million in 2022, then sank by 78.19% to $4.3 million in 2023, then retreated by 29.63% to $3.1 million in 2024, then retreated by 16.13% to $2.6 million in 2025.
  • Business Quant data shows IVVD's Share-based Compensation at $2.6 million in Q4 2025, $12.7 million in Q3 2025, and $3.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn - 6.39 Mn
2 Nanobiotix 1,909.44 Bn 1,909.38 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - 305,000.00
4 BeOne Medicines 471.58 Bn 466.79 Bn 1.35 Bn 9.26 Mn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 69.93 Bn 61.18 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.80 Bn 50.61 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn -
10 Invivyd 104.45 Mn -122.24 Mn 16.07 Mn 2.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.56 Mn
Dec 31, 2025 2.56 Mn
Sep 30, 2025 12.70 Mn
Sep 30, 2025 12.70 Mn
Jun 30, 2025 3.18 Mn
Jun 30, 2025 3.18 Mn
Mar 31, 2025 19.00 Mn
Mar 31, 2025 19.00 Mn
Dec 31, 2024 3.06 Mn
Dec 31, 2024 3.06 Mn
Sep 30, 2024 2.87 Mn
Sep 30, 2024 2.87 Mn
Jun 30, 2024 8.49 Mn
Jun 30, 2024 8.49 Mn
Mar 31, 2024 5.38 Mn
Mar 31, 2024 5.38 Mn
Dec 31, 2023 4.34 Mn
Dec 31, 2023 4.34 Mn
Sep 30, 2023 4.26 Mn
Sep 30, 2023 4.26 Mn